FASENRA
FASENRA
Approved
DIN Number
02473232
Drug Class
Human
Market Date
Mar 28, 2018
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473232
AIG Number0159970001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
R03DX10 BENRALIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification48:10.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
BENRALIZUMABActive
Strength: 30 MG / ML
Monograph: BENRALIZUMAB